Guardant Health, Inc. 4

Chief Commercial Officer Chris Freeman exercised stock options to acquire 63,605 Guardant Health (GH) shares and sold 63,605 shares on August 10, 2026, resulting in direct ownership of 65,374 shares.

On August 10, 2026, Guardant Health, Inc. Chief Commercial Officer Chris Freeman exercised two stock option grants, acquiring 35,412 shares of common stock at $110.49 per share and 28,193 shares at $28.37 per share, and then sold a total of 63,605 shares in multiple open-market transactions at weighted average prices between approximately $167.38 and $170.24 per share. The option exercises, which relate to awards granted in 2021 and 2023, brought in stock at a substantial discount to the prevailing market prices, and the subsequent sales appear structured as partial monetization of those exercises. Following these transactions, Freeman’s direct beneficial ownership increased to 65,374 shares of Guardant Health common stock, indicating that despite the sizable sales, he retained a meaningful equity stake in the company.

Filing Facts

CIK

1576280

Ticker

GH

Form

4

Source Type

sec

Accession

0001871615-26-000016

Alert Tier

7